NEWS & EVENTS
Sep 16 2015

PRESS RELEASE: "ZOLL ANNOUNCES ACQUISITION OF KYMA MEDICAL
TECHNOLOGIES"

ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, today announced that it has acquired Tel Aviv, Israel-based Kyma Medical Technologies, Ltd., which develops technologies to measure early signs of congestive heart failure.

Access Press Release

Mar 04 2015

KYMA TO PRESENT AT ATA 2015: THE 20TH ANNUAL TELEMEDICINE
MEETING AND TRADE SHOW, MONDAY MAY 4, 2015

Kyma is pleased to have been selected to present at the 2015 ATA Meeting And Trade Show. The presentation, titled: "Noninvasive Lung Water Determination Using Novel Radiofrequency Technology: Clinical Validation," will take place on Monday, May 4, 2015, at 4:15 PM, at the LA Convention Center.

Jan 22 2015

KYMA ANNOUNCES CE MARK FOR ITS NEXT GENERATION µCOR SYSTEM

The next-generation µCor System expands upon the previous platform to monitor a patient’s thoracic fluid content along with other important vital signs in different clinical and home environments. CE Mark of the next generation device marks a milestone in the company’s development plan and enables the company to pursue new business opportunities.

Dec 20 2014

RESULTS FROM ANIMAL STUDY PUBLISHED IN THE JOURNAL "CRITICAL CARE"

Results from an animal study comparing Kyma RF Fluid Index (RFFI) and invasive extra-vascular lung water measurement published in Crit Care. 2014; 18(Suppl 1): P137.

Sep 16 2014

KYMA ANNOUNCED AS SECOND PLACE WINNER OF THE 2014 TCT
INNOVATIVE CARDIOVASCULAR TECHNOLOGIES AWARD

After being selected to give an oral presentation at the prestigious annual TCT event, Kyma was announced yesterday as the second place winner of the 2014 Innovative Cardiovascular Technologies Award.

Sep 1 2014

KYMA TO PRESENT AT THE TCT INNOVATION SESSION,
SUNDAY, SEPTEMBER 14, 2014

Kyma is pleased to present at the 2014 TCT Innovation Session. The presentation, titled: " A Novel Modality for Monitoring Tissue Hydration in Congestive Heart Failure Patients: Technology Overview and FIH Results" will take place on Sunday, September 14, Washington DC, at 2:55 PM.Click here to access the full agenda on the TCT website

Aug 5 2014

KYMA TO PRESENT AT THE 23RD ICISA

Kyma accepted to give an oral poster presentation at the 23rd International Congress of the Israel Society of Anesthesiologists and critical care (ICISA 2014) taking place September 16-18, 2014 in Tel-Aviv, Israel.

JUNE 20 2014

KYMA TO PRESENT AT THE HFSA 2014 SCIENTIFIC MEETING

KYMA accepted to present two posters at the HFSA Annual Scientific Meeting taking place September 14-17, 2014 in Las Vegas, Nevada.

APR 15 2014

KYMA TO PRESENT THREE ABSTRACTS AT HEART
FAILURE 2014 CONGRESS

Kyma will present three posters at the ESC Heart Failure congress held in Athens, Greece, 17-20 May 2014.

FEB 10 2014

KYMA TO PRESENT A POSTER AT THE 34TH ISICEM, MARCH 18-21, 2014,
BRUSSELS, BELGIUM

The poster - "Novel technology for Non-Invasive Thoracic Fluid Measurement – an Animal Model Comparative Study", will be presented at the 34th International Symposium on Intensive Care and Emergency Medicine taking place March 18-21, 2014 in Brussels, Belgium.

JAN 1 2014

KYMA OPENS A SUBSIDIARY IN THE UNITED STATES

Kyma has opened a subsidiary in the US that will support the company's activities in the US market over the coming years. The company has recently initiated clinical activity in leading centers in the US as preparation for market launch.

DEC 15 2013

KYMA LAUNCHED CLINICAL TRIAL AT THE MAYO CLINIC

Kyma has launched a clinical trial at the Mayo Clinic. The trial will recruit up to 60 patients over a two-year period, and is designed to test the usability of the Kyma µ-Cor and establish its efficacy in predicting lung fluid congestion.

OCT 7 2013

KYMA SECURES $10 MILLION FINANCING ROUND

Kyma Medical Technologies closes a $10 million investment round led by Ganot Capital LLC, the venture capital arm of family firm Ganot Ltd., a leading elderly care company in the US. Kyma's first investors, Elron Electronic Industries Ltd. (TASE: ELRN) and Rafael Development Corporation (RDC) also participated in the financing round.

Read article in Globes